SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-22-027122
Filing Date
2022-10-26
Accepted
2022-10-26 20:00:34
Documents
1
Period of Report
2022-10-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_166682881646748.html 4  
1 FORM 4 wf-form4_166682881646748.xml 4 10436
  Complete submission text file 0001628280-22-027122.txt   11773
Mailing Address 21 ERIE ST. CAMBRIDGE MA 02139
Business Address 21 ERIE ST. CAMBRIDGE MA 02139 617-465-0013
Prime Medicine, Inc. (Issuer) CIK: 0001894562 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address PRIME MEDICINE, INC. 21 ERIE ST. CAMBRIDGE MA 02139
Business Address
Cahill Thomas (Reporting) CIK: 0001922939 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41536 | Film No.: 221334511